Tech Company Financing Transactions
Chinook Therapeutics Funding Round
Chinook Therapeutics, based in Vancouver BC, scored $65 million in investment from Versant Ventures, Apple Tree Partners and Samsara BioCapital.
Transaction Overview
Company Name
Announced On
8/23/2019
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series A
Investors
Versant Ventures (Lead Investor) (Jerel Davis)
Apple Tree Partners (Sam Hall)
Samsara BioCapital (Srini Akkaraju)
Proceeds Purpose
The Series A proceeds will fund the advancement of several kidney disease programs into clinical trials by 2021.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
887 Great Northern Way 210
Vancouver BC, V5T 4T5
Canada
Vancouver BC, V5T 4T5
Canada
Phone
Undisclosed
Website
Email Address
Overview
Chinook Therapeutics is a biotechnology company developing precision medicines for kidney diseases. Kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Dobmeier
Chief Medical Officer
Alan Glicklich
Controller
Ramtin Jamshidi
Vice President
Renata Oballa
VP - Bus. Development
Thomas Frohlich
VP - Bus. Development
Allison Gaw
VP - Finance
Thomas Swallow
VP - General Counsel
Kirk Schumacher
VP - Human Resources
Jodi Jamieson
VP - Regulatory Affairs
Valerie Fauvelle
Browse more venture capital transactions:
Prev: 8/23/2019: CropX venture capital transaction
Next: 8/23/2019: Praemo venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. All VC database entries on this site come from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs